Mike Hollan

AI-powered radiology solutions can be used with both chest x-rays and breast cancer detection.

The agency teamed up with the software company to develop platforms and networks to collect de-identified data.

Orne discusses the forces impacting the life sciences market and how companies are reacting.

Ito discusses how data-driven AI can be utilized by the pharma industry.

Industry experts discuss the relationship between digital and traditional (key) opinion leaders and how companies are adjusting their strategies to harness the unique brand engagement benefits each role can provide in driving better patient outcomes.

Klein discusses how recent FDA draft guidelines will impact the use of SaMD in the life sciences industry.

Kirsch discusses the complexity of the drugs and the verification process, along with EVERSANA’s new platform, ACTICS eAccess.

Accenture’s global life sciences technology lead discusses how the life sciences industry has embraced artificial intelligence.

Limaca Medical’s device had previously received a breakthrough device designation from FDA.

The device used a headset with a virtual display to provide information to surgeons during procedures.

The device provides surgeons with GPS-like guidance.

This will allow the product to arrive in hospitals at a faster pace.

The technology, created by IceCure Medical, freezes tumors and is an alternative to surgical intervention.

OnPoint, a group of privately held AR companies, will present the platform.

Abid Rahman and Mike DeLuca discuss developing the AI-powered chatbot.

Arkell discusses the need to democratize AI for the healthcare industry.

AcuityMD’s CEO speaks about the current market and how its impacting smaller medical device companies.

The company also announced a new automation facility to be located in Shanghai.

The FDA granted 501(k) clearance to Fresenius’ Versi HD with GUideMe Software. The device will be available in select markets at some point in 2023, and previous models will be upgradeable.

The CEO spoke about recent mergers and testing for Alzheimer’s.

Research and Market’s report also says that the medical animation market will grow by a CGAR of 19.9% in the next decade.

The MARS platform combines magnets and machinery.

The device, developed by magAssist, is an interventional ventricular assistance device.

The virtual health and remote care company is partnering with BioIntelliSense and Stel Life.

A new report details the factors expected to drive the market’s growth in the coming years.

Several of Gleamer’s digital products will be incorporated into the ConcertAI platform.

The AR-focused company will present its platform on August 15, 2023.

The non-invasive device can be used to monitor the heart in a variety of ways.

A new report from Allied Market Research attributed multiple causes for the increase.

The devices will be available commercially in October 2023.